Clinical Trial Update: Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 randomized, open-label study comparing guadecitabine versus treatment choice in previously treated acute myeloid leukemia has completed and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Guadecitabine (guadecitabine)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2023-05-25